Company / Operating Income per Share
United Therapeutics Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
$33.29
FY2025
5-year range
$12.49 / $33.29
FY2021-FY2025
Trend
+13.7%
vs FY2024
Sector context
#2 of 201
Health Care
What the data says
Among 201 Health Care companies, United Therapeutics is in the top 1% for operating income per share. Operating Income per Share has increased for 4 consecutive years, from $12.49 in FY2021 to $33.29 in FY2025.
Based on SEC 10-K filings.
33.29 in FY2025 with a 5-year CAGR of +19.7%. Ranks 2nd among 201 companies in Health Care.
Improved from $25.74 to $33.29 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- +15.3%
- 5-Year CAGR
- +19.7%
- 10-Year CAGR
- -
Sector benchmark
+216.6% above sector average
Key checks
Key Insights
- United Therapeutics's operating income per share has grown for 4 consecutive years.
- In FY2025, operating income per share increased 13.7% year-over-year.
- Ranks #2 out of 201 companies in the Health Care sector.
- Lowest operating income per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $33.29 | +13.7% |
| FY2024 | $29.27 | +13.7% |
| FY2023 | $25.74 | +18.5% |
| FY2022 | $21.72 | +73.9% |
| FY2021 | $12.49 | -7.7% |
| FY2020 | $13.53 | +414.3% |
| FY2019 | -$4.30 | -123.1% |
| FY2018 | $18.63 | +14.5% |
| FY2017 | $16.27 | -29.9% |
| FY2016 | $23.20 | +56.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026